Regulation of Vascular Endothelial Growth Factor (VEGF) Splicing from Pro-angiogenic to Anti-angiogenic Isoforms-Reference-Cited by-同舟云学术

Regulation of Vascular Endothelial Growth Factor (VEGF) Splicing from Pro-angiogenic to Anti-angiogenic Isoforms

Published:2010-02 Issue:8 Volume:285 Page:5532-5540
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Nowak Dawid G.,Amin Elianna Mohamed,Rennel Emma S.,Hoareau-Aveilla Coralie,Gammons Melissa,Damodoran Gopinath,Hagiwara Masatoshi,Harper Steven J.,Woolard Jeanette,Ladomery Michael R.,Bates David O.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference53 articles.

1. Tumor Angiogenesis

2. Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox.

3. IGF-1–Induced VEGF and IGFBP-3 Secretion Correlates with Increased HIF-1α Expression and Activity in Retinal Pigment Epithelial Cell Line D407

4. VEGF-A splicing: the key to anti-angiogenic therapeutics?

5. The Vascular Endothelial Growth Factor Family: Identification of a Fourth Molecular Species and Characterization of Alternative Splicing of RNA

Cited by 176 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LTR retrotransposon-derived LncRNA LINC01446 promotes hepatocellular carcinoma progression and angiogenesis by regulating the SRPK2/SRSF1/VEGF axis;Cancer Letters;2024-08

2. Long noncoding RNA MALAT-1: A versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistance;Non-coding RNA Research;2024-06

3. The splicing factor kinase SRPK1 is a therapeutic target for Peripheral Vascular Disease;2024-04-22

4. The host transcriptional response to superinfection by influenza A virus and Streptococcus pneumoniae;mSystems;2024-04-16

5. A patent perspective of antiangiogenic agents;Expert Opinion on Therapeutic Patents;2023-12-02